Patients with advanced bladder cancer that had spread to other parts of the body (metastasized) have responded well in a phase I clinical trial of an investigational drug, TYRA-300.

Six-monthly HIV drug, lenacapavir, reduced HIV incidence by 96 per cent in trial. Affordability and supply remain key hurdles for rollout.

There is compelling evidence that bacteria, parasites, viruses, and fungi are developing resistance to antimicrobials. As a ...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Stage IV cancers have spread (metastasized) beyond the breast and nearby lymph nodes to other parts of the body. When breast cancer spreads, it most commonly goes to the bones, liver, and lungs. It ...

“Those who have a Medicare Advantage plan through Humana should make sure to read the notice of creditable drug coverage they received in the mail by Oct. 15. Otherwise, they might find ...

No. 48 / 2024Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinismU.S. Food and ...

According to the findings the drug successfully penetrated the cells and reduced the buildup of Tau proteins. The researchers plan to test the drug in rodents, before moving on to clinical trials.

Real Chemistry has partnered with Corval to add a commercialization planning and launch platform ... company needs to do—and when—to get the drug to market. The idea is to define the ...